Impact of empagliflozin in patients with diabetes and heart failure
D Pham, NDA Rocha, DK McGuire… - Trends in cardiovascular …, 2017 - Elsevier
Heart failure (HF) is a common disease with increased risk for mortality and morbidity among
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
Impact of empagliflozin in patients with diabetes and heart failure.
D Pham, DK McGuire, IJ Neeland - Trends in Cardiovascular …, 2016 - europepmc.org
Heart failure (HF) is a common disease with increased risk for mortality and morbidity among
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
Impact of empagliflozin in patients with diabetes and heart failure
D Pham, NDA Rocha, DK McGuire… - Trends in …, 2017 - pubmed.ncbi.nlm.nih.gov
Heart failure (HF) is a common disease with increased risk for mortality and morbidity among
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
[引用][C] Impact of empagliflozin in patients with diabetes and heart failure
D Pham, RND Albuquerque, DK McGuire… - Trends in …, 2017 - elibrary.ru
Impact of empagliflozin in patients with diabetes and heart failure
D Pham, NDA Rocha… - Trends in …, 2017 - utsouthwestern.elsevierpure.com
Heart failure (HF) is a common disease with increased risk for mortality and morbidity among
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
[HTML][HTML] Impact of Empagliflozin in Patients with Diabetes and Heart Failure
D Pham, NDA Rocha, DK McGuire… - Trends in cardiovascular …, 2017 - ncbi.nlm.nih.gov
Heart failure (HF) is a common disease with increased risk for mortality and morbidity among
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
Impact of empagliflozin in patients with diabetes and heart failure
D Pham, NDA Rocha, DK McGuire… - Trends in Cardiovascular …, 2017 - infona.pl
Heart failure (HF) is a common disease with increased risk for mortality and morbidity among
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …
patients with type 2 diabetes mellitus (T2DM). Optimal glycemic control in this patient …